Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Encompass Health (EHC)

Encompass Health raises 2024 guidance as Q3 revenue rises 11.9% to $1.35 billion

Positive Impact 4 of 5 guidance Written later

Encompass Health reported third-quarter 2024 net operating revenue of $1.35 billion, up 11.9% from a year earlier, and diluted earnings per share from continuing operations of $1.07, up from $0.85. The company raised its full-year 2024 guidance for revenue, Adjusted EBITDA and adjusted earnings per share, though it noted challenging conditions from Hurricanes Helene and Milton.

Key points

  • Q3 2024 net operating revenue was $1,351.0 million versus $1,206.9 million in Q3 2023; discharges rose 8.8%, including 6.8% same-store growth.
  • Adjusted EBITDA was $269.3 million, up 13.4%; adjusted earnings per share was $1.03 versus $0.86.
  • Full-year 2024 guidance raised: net operating revenue to $5,325 million to $5,375 million (from $5,275 million to $5,350 million) and adjusted EBITDA to $1,070 million to $1,090 million (from $1,040 million to $1,075 million).
  • Adjusted earnings per share guidance raised to $4.19 to $4.33 from $3.97 to $4.22; earnings call is at 10:00 a.m. Eastern on October 29, 2024.

The filing

CompanyEncompass Health (EHC)
Form8-K, current report
Filed with the SECOct 28, 2024, 4:33 PM ET
Accession number0000785161-24-000047

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:12 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 28, 2024.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.